QDOLO™ provides the clinical benefits of tramadol hydrochloride in an oral solution that enables precise dosing, simplifies titration, and provides an easy to swallow medicine for patients with dysphagia. The U.S. Department of Health and Human Services report on pain management best practices emphasizes the need for an individualized, patient-centered approach for the treatment of pain.1
Precise, Individualized Dosing
As an oral liquid, QDOLO provides the flexibility and precision to individually titrate to a dose to provide adequate analgesia and minimize adverse reactions. This allows for the use of the lowest effective dosage for the shortest duration, consistent with individual patient treatment goals. 2
The dosing regimen can be initiated for each patient individually with QDOLO, taking into account the patient’s severity of pain, response, prior analgesic treatment experience, and risk factors.2
Help for Patients with Dysphagia
Dysphagia affects up to 15 million adults in the US, and 1 in 25 people will experience some form of dysphagia in their lifetime.3 As a liquid oral solution, QDOLO may help your patients who have difficulty swallowing tramadol in tablet form.
- U.S. Department of Health and Human Services (2019, May). Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations. Retrieved from U. S. Department of Health and Human Services website: https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html
- QDOLO [prescribing information]. Athens, GA: Athena Bioscience, LLC; 2020.
- ASHA, 2008; Bhattacharyya, 2014.